ST易联众收盘上涨2.93%，最新市净率6.34，总市值18.15亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of ST Yilianzhong, indicating a significant decline in revenue and net profit for the third quarter of 2024 compared to the previous year [2] - As of March 31, ST Yilianzhong's stock closed at 4.22 yuan, marking a 2.93% increase, with a latest price-to-book ratio of 6.34, which is the lowest in 238 days, and a total market capitalization of 1.815 billion yuan [1] - The company has experienced a net inflow of main funds amounting to 11.04 million yuan on March 31, with a total inflow of 29.93 million yuan over the past five days, indicating a positive trend in fund movement [1] Group 2 - For the third quarter of 2024, ST Yilianzhong reported an operating income of 335 million yuan, reflecting a year-on-year decrease of 29.72%, and a net profit loss of approximately 67.99 million yuan, which is a 153.10% decline compared to the previous year [2] - The company's gross profit margin stands at 46.38%, which is a critical metric for assessing its profitability in the current market environment [2] - The company has received several accolades for its contributions to digital healthcare and technology, including awards for its blockchain achievements and innovative digital health applications [1]